AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

INGN · NASDAQ · Medical - Devices

Inogen

Provides portable oxygen and respiratory devices through consumer, provider, and distributor channels.

$5.50

After-hours close−0.00 (−0.09%)

At close$5.51(−0.09%)

Something off on this page? Send us feedback.

Profile

Inogen, Inc.INGNHealth Care

Generates revenue from portable oxygen concentrators, airway clearance, stationary oxygen, and CPAP-mask products. U.S. direct-to-consumer sales and rentals sit alongside sales through home medical equipment and distribution channels, including an international footprint.

Portable oxygen concentrators under the Inogen One and Inogen Rove brands provide supplemental long-term oxygen therapy for people with chronic respiratory conditions. The portfolio also includes the Simeox airway-clearance system, Voxi 5 stationary oxygen concentrators, and Aurora CPAP masks.

In the United States, products are sold and rented directly to consumers and sold through home medical equipment providers, distributors, and resellers. Outside the United States, sales run through distributors, resellers, home medical equipment providers, and large house accounts across many countries.

Research and development focuses on functionality, ease of use, total cost of ownership, next-generation concentrators, and Simeox. The business depends on regulated-device manufacturing, quality systems, commercial channels, and respiratory-product development.

Company facts

CEOKevin R.M. Smith

ListedFeb 14, 2014

ExchangeNASDAQ

HeadquartersBeverly, MA

CountryUnited States

Employees753

CIK0001294133

ISINUS45780L1044

Key statistics

Market cap$148.9M

EPS (ttm)−$0.9000

P/E (ttm)−6.11

ROE-13.2%

P/B0.8506

P/S0.4203

Dividend yield—

Beta0.52vs XLV 0.57

Year to date −17.0% · Average volume (30d) 240.4K

Analysts

Price target, next 12 months$26.00+372.7%Median of 11 analysts · vs the Aug 28 close

ConsensusBuy6 of 11 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $5.50

High$26.00+372.7%

Median$26.00+372.7%

Low$26.00+372.7%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Prior rating	Rating
May 22, 2025	Needham	Upgrade	Hold	Buy

Earnings

EPS

Estimate−$0.11

ReportedDue Nov 4, 2026

Revenue

Estimate$92.3M

ReportedDue Nov 4, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 6, 2026Q2 FY26	−$0.15	−$0.14	+8.7%	$95.2M	$95.1M	−0.2%	−6.78%
May 7, 2026Q1 FY26	−$0.24	−$0.30	−25.0%	$82.4M	$85.1M	+3.4%	−2.36%
Feb 24, 2026Q4 FY25	−$0.36	−$0.26	+27.8%	$85.1M	$81.7M	−3.9%	+2.91%
Nov 5, 2025Q3 FY25	−$0.22	−$0.20	+9.1%	$88.6M	$92.4M	+4.3%	−4.87%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$82.3M	$92.3M	$92.4M	$81.7M	$85.1M	$95.1M
Gross profit	$36.4M	$41.3M	$47.0M	$41.2M	$41.8M	$43.3M
Operating income	−$7.7M	−$6.1M	−$7.1M	−$9.3M	−$8.4M	−$5.1M
Net income	−$6.2M	−$4.2M	−$5.3M	−$7.1M	−$8.3M	−$3.9M
Diluted EPS	−$0.25	−$0.15	−$0.20	−$0.26	−$0.30	−$0.14
Gross margin	44.2%	44.8%	50.8%	50.4%	49.1%	45.5%
Operating margin	-9.3%	-6.6%	-7.7%	-11.4%	-9.9%	-5.4%

Fiscal years (4-quarter sums)FY21 $358.0M · FY22 $377.2M · FY23 $315.7M · FY24 $335.7M · FY25 $348.7M

Revenue by geography · Q2 FY26

United States$53.8M · 57%

Non-US$41.3M · 43%

Balance sheet, Jun 30, 2026Cash & short-term investments $105.5M · Total debt $15.8M · Total assets $285.6M · Shareholders' equity $174.9M

Dividends

No dividends on record.

Ownership

Institutions 71.37%19.32M sharesInsiders 3.09%835.5K sharesOther 25.54%6.92M shares

Shares outstanding 27.07M · Float 23.68M · 87.5% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Yuwell (Hong Kong) Holdings Limited	2.63M	9.90%	13G	Feb 24, 2025
BlackRock, Inc.	1.75M	6.46%	13F	Aug 7, 2026
Acadian Asset Management LLC	1.10M	4.05%	13F	Aug 13, 2026
Armistice Capital, LLC	1.10M	4.05%	13F	Aug 14, 2026
Vanguard Capital Management LLC	1.04M	3.84%	13F	Aug 13, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Jul 1, 2026	Boyer Jennifer M. Yi	officer: EVP Entrprs Enblmnt, Ch HR Off	−10,938	$6.60
May 29, 2026	Boyer Jennifer M. Yi	officer: EVP Entrprs Enblmnt, Ch HR Off	−10,770	$6.53